Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 43 articles:
HTML format



Single Articles


    April 2025
  1. THEL H, Latour CD, Tsevat D, Dissanayake M, et al
    Prevalence of male and female permanent contraception and long-acting reversible contraceptives among commercially insured US population, 2010-2022.
    Am J Obstet Gynecol. 2025 Apr 18:S0002-9378(25)00230.
    PubMed    


    March 2025
  2. MAZZA D, Assifi AR, McGeechan K, Haas M, et al
    Increasing the uptake of long-acting reversible contraception through family practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial 3-year follow-up.
    Am J Obstet Gynecol. 2025 Mar 20:S0002-9378(25)00166.
    PubMed     Abstract available


  3. ALLISON BA, Glodowski CR, Smith C, Mizelle C, et al
    Effectiveness of Interventions to Support Person-Centered Contraceptive Care for Adolescents and Young Adults: A Systematic Review.
    Am J Obstet Gynecol. 2025 Mar 20:S0002-9378(25)00162.
    PubMed     Abstract available


  4. KRASHIN JW, Rivera-Montalvo M, Leeman L, Trujillo VY, et al
    Breastfeeding after immediate versus delayed postpartum contraceptive implant placement: a non-inferiority randomized controlled trial.
    Am J Obstet Gynecol. 2025 Mar 20:S0002-9378(25)00165.
    PubMed     Abstract available


    September 2024
  5. PROVINCIATTO H, Meirelles Dias YJ, Abonizio Magdalena SL, Barbosa Moreira MV, et al
    Immediate versus delayed postpartum insertion of long-acting reversible contraception methods: meta-analysis of randomized controlled trials.
    Am J Obstet Gynecol. 2024 Sep 18:S0002-9378(24)00931.
    PubMed     Abstract available


    August 2024
  6. MATOVINA CN, Sakowicz A, Allen EC, Alvarado-Goldberg MI, et al
    Effect of Covid-19 pandemic on postpartum depression and contraception.
    Am J Obstet Gynecol. 2024 Aug 17:S0002-9378(24)00843.
    PubMed    


  7. RIDGEWELL B, Callins K
    Postpartum depressive symptoms and contraception.
    Am J Obstet Gynecol. 2024 Aug 17:S0002-9378(24)00842.
    PubMed    


  8. CHAPPELL CA, Lamorde M, Nakalema S, Kyohairwe I, et al
    A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy.
    Am J Obstet Gynecol. 2024;231:242.
    PubMed     Abstract available


    July 2024
  9. SUZUKI Y, Ferris JS, Chen L, Dioun S, et al
    Fertility-preserving Treatment for Stage IA Endometrial Cancer: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2024 Jul 18:S0002-9378(24)00761.
    PubMed     Abstract available


  10. RICKER EA, Koltun KJ, DE LA Motte SJ
    Female Service Members Deserve an Individualized Approach to Hormonal Contraception Counseling.
    Am J Obstet Gynecol. 2024 Jul 11:S0002-9378(24)00752.
    PubMed    


  11. KINKAID V, Morris K, Guest R
    Hormonal Contraception and Medical Readiness for Female Service Members: A comment.
    Am J Obstet Gynecol. 2024 Jul 11:S0002-9378(24)00751.
    PubMed    


  12. KERNS JL, Keder LM, Cwiak CA, Westhoff CL, et al
    Hormone-related side effects in new users of a levonorgestrel 52 mg intrauterine device.
    Am J Obstet Gynecol. 2024 Jul 3:S0002-9378(24)00743.
    PubMed     Abstract available


    June 2024
  13. MILLER CE, Kim JH, Kroll R, Simon JA, et al
    Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: 12 months of an ongoing randomized phase 3 trial.
    Am J Obstet Gynecol. 2024 Jun 30:S0002-9378(24)00731.
    PubMed     Abstract available


    May 2024
  14. RICKER EA, Koltun KJ, de la Motte SJ
    Hormonal Contraception and Medical Readiness for Female Service Members.
    Am J Obstet Gynecol. 2024 May 27:S0002-9378(24)00630.
    PubMed     Abstract available


  15. YI H, Zhang N, Huang J, Zheng Y, et al
    Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden.
    Am J Obstet Gynecol. 2024 May 15:S0002-9378(24)00593.
    PubMed     Abstract available


  16. AMES JL, Anderson MC, Cronbach E, Lee C, et al
    Reproductive healthcare in adolescents with autism and other developmental disabilities.
    Am J Obstet Gynecol. 2024;230:546.
    PubMed     Abstract available


    April 2024
  17. LO FARO V, Johansson A
    Genotyping oral contraceptive users for venous thromboembolism risk.
    Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00565.
    PubMed    


  18. VERCELLINI P, Artoni A, Abbattista M, Martinelli I, et al
    PREDICTION OF VENOUS THROMBOEMBOLISM IN AVERAGE-RISK YOUNG CANDIDATES FOR ORAL CONTRACEPTIVE USE: TO GENOTYPE, OR NOT TO GENOTYPE, THAT IS THE QUESTION.
    Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00564.
    PubMed    


    March 2024
  19. MATOVINA CN, Sakowicz A, Allen EC, Alvarado-Goldberg MI, et al
    The association between postpartum depressive symptoms and contraception.
    Am J Obstet Gynecol. 2024 Mar 27:S0002-9378(24)00472.
    PubMed     Abstract available


  20. SANCHEZ-RAMOS L, Levine LD, Sciscione AC, Mozurkewich EL, et al
    Methods for the induction of labor: efficacy and safety.
    Am J Obstet Gynecol. 2024;230.
    PubMed     Abstract available


  21. CHESNOKOVA A, Christensen T, Streaty T, McAllister A, et al
    Medicaid compared to private insurance is associated with lower rates of sterilization in people with unwanted births.
    Am J Obstet Gynecol. 2024;230:347.
    PubMed     Abstract available


    February 2024
  22. TORRES E, Carter G, Gero A, Simmons RG, et al
    Frequency of same-day start contraceptive initiation, recent unprotected intercourse, and pregnancy risk: a prospective cohort study of multiple contraceptive methods.
    Am J Obstet Gynecol. 2024 Feb 15:S0002-9378(24)00083.
    PubMed     Abstract available


    January 2024
  23. PLAGIANOS MG, Ramanadhan S, Merkatz RB, Brache V, et al
    Risk Factors for and Outcomes of Ring Expulsions with a One Year Contraceptive Vaginal System.
    Am J Obstet Gynecol. 2024 Jan 29:S0002-9378(24)00061.
    PubMed     Abstract available


  24. HUIJS DPC, Derickx AJM, Beelen P, Leemans JC, et al
    A 52 mg levonorgestrel-releasing intrauterine system versus bipolar radiofrequency non-resectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multi-center randomized controlled trial.
    Am J Obstet Gynecol. 2024 Jan 25:S0002-9378(24)00045.
    PubMed     Abstract available


    December 2023
  25. GUO XM, Lim LM, Matsuzaki S, Matsuo K, et al
    Research on intrauterine manipulators for endometrial cancer: Attention to study-level characteristics.
    Am J Obstet Gynecol. 2023 Dec 8:S0002-9378(23)02122.
    PubMed    


    October 2023
  26. DANVERS AA, Gurney EG, Panushka K, Peskin M, et al
    Shortcomings and Disparities in Contraception Counseling and Use by Hypertensive Individuals at Risk for Unintended Pregnancy: A Comparative Analysis of the National Survey of Family Growth 2015-2019.
    Am J Obstet Gynecol. 2023 Oct 21:S0002-9378(23)00768.
    PubMed     Abstract available


    September 2023
  27. LO FARO V, Johansson T, Johansson A
    The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank.
    Am J Obstet Gynecol. 2023 Sep 19:S0002-9378(23)00618.
    PubMed     Abstract available


    August 2023
  28. MATTESON KA, Valcin J, Raker CA, Clark MA, et al
    A randomized trial comparing the 52-mg levonorgestrel system to combination oral contraceptives for treatment of heavy menstrual bleeding.
    Am J Obstet Gynecol. 2023 Aug 1:S0002-9378(23)00521.
    PubMed     Abstract available


    July 2023
  29. EASTIN EF, Nelson DA, Shaw JG, Shaw KA, et al
    Postpartum long-acting reversible contraceptive use among active-duty, female U.S. Army soldiers.
    Am J Obstet Gynecol. 2023 Jul 15:S0002-9378(23)00471.
    PubMed     Abstract available


  30. CATHCART AM, Nezhat FR, Fitch KC, Nguyen CGT, et al
    Trends in permanent contraceptive procedural volume in the United States between 2019 and 2020.
    Am J Obstet Gynecol. 2023 Jul 15:S0002-9378(23)00467.
    PubMed    


  31. CREININ MD, Jensen JT
    Extending use of levonorgestrel 52 mg intrauterine device to 8 years.
    Am J Obstet Gynecol. 2023;229:84.
    PubMed    


  32. GOLDBERG AB
    Extending the use of levonorgestrel 52 mg intrauterine devices to 8 years.
    Am J Obstet Gynecol. 2023;229:85.
    PubMed    


    June 2023
  33. SWAN LET, Cutler AS, Higgins JA
    Response to Letter to the Editor Regarding Physician Beliefs about Contraceptives as Abortifacients.
    Am J Obstet Gynecol. 2023 Jun 15:S0002-9378(23)00412.
    PubMed    


  34. BEITER KA, Stanford JB
    Contraceptives as abortifacients.
    Am J Obstet Gynecol. 2023 Jun 15:S0002-9378(23)00411.
    PubMed    


    April 2023
  35. EDELMAN A, Boniface E, Schrote K, Messerle-Forbes M, et al
    Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
    Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00265.
    PubMed     Abstract available


    March 2023
  36. PHILLIPS AM, Rachad S, Flink-Bochacki R
    The association between abortion restrictions and patient-centered care for early pregnancy loss at U.S. OB/GYN residency programs.
    Am J Obstet Gynecol. 2023 Mar 30:S0002-9378(23)00223.
    PubMed     Abstract available


  37. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    PubMed     Abstract available


  38. ZHANG J, Zhu C, Yan L, Wang Y, et al
    Comparing levonorgestrel intrauterine system versus hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open label, controlled trial.
    Am J Obstet Gynecol. 2023 Mar 17:S0002-9378(23)00167.
    PubMed     Abstract available


  39. LEVINE EM
    Extended use of the Levonorgestrel Intrauterine System for Contraception.
    Am J Obstet Gynecol. 2023 Mar 16:S0002-9378(23)00160.
    PubMed    


  40. THURMAN AR, Moench TR, Hoke M, Politch JA, et al
    ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
    Am J Obstet Gynecol. 2023 Mar 2:S0002-9378(23)00139.
    PubMed     Abstract available


    December 2022
  41. HEALY A, Davidson C, Allbert J, Bauer S, et al
    Telemedicine in obstetrics, quality and safety considerations.
    Am J Obstet Gynecol. 2022 Dec 5:S0002-9378(22)02261.
    PubMed     Abstract available


    October 2022
  42. FELS LM, Costescu D, Vieira CS, Peipert JF, et al
    The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    Am J Obstet Gynecol. 2022 Oct 29:S0002-9378(22)00835.
    PubMed     Abstract available


    June 2022
  43. NAGENDRA D, Gutman SM, Koelper NC, Loza-Avalos SE, et al
    Medical management of early pregnancy loss is cost-effective compared to office uterine aspiration.
    Am J Obstet Gynecol. 2022 Jun 30. pii: S0002-9378(22)00530.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.